Get started
Author

Elly Marcq

Observed names: E Marcq, E. Marcq, Marcq, Elly
ORCID: 0000-0003-3173-0500
Observed ORCID: 0000-0003-3173-0500
OpenAlex ID: A5032025948
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells
2019 · Jinthe Van Loenhout, Tal Flieswasser, et al. · Cancers · 117
PDF
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
2024 · Astrid Van den Eynde, Laura Gehrcken, et al. · Journal of Hematology & Oncology · 102
PDF
Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer
2018 · Maarten Versteven, Johan M. J. Van den Bergh, et al. · Frontiers in Immunology · 97
PDF
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
2016 · Elly Marcq, Vasiliki Siozopoulou, et al. · OncoImmunology · 88
PDF
Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells
2016 · Stijn Vermeylen, Jorrit De Waele, et al. · Plasma Processes and Polymers · 69
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
2017 · Jonas R.M. Van Audenaerde, Jorrit De Waele, et al. · Oncotarget · 68
PDF
Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
2017 · Elly Marcq, Jorrit De Waele, et al. · Oncotarget · 57
PDF
NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
2021 · Vasiliki Siozopoulou, Evelien Smits, et al. · Diagnostics · 54
PDF
Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?
2021 · Vasiliki Siozopoulou, Andreas Domen, et al. · Cancers · 48
PDF
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
2017 · Jorrit De Waele, Elly Marcq, et al. · OncoImmunology · 47
PDF
Targeting immune checkpoints: New opportunity for mesothelioma treatment?
2015 · Elly Marcq, Patrick Pauwels, et al. · Cancer Treatment Reviews · 41
PDF
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
2020 · Jonas RM Van Audenaerde, Elly Marcq, et al. · Clinical & Translational Immunology · 40
PDF
The effect of local non‐thermal plasma therapy on the cancer‐immunity cycle in a melanoma mouse model
2022 · Abraham Lin, Joey De Backer, et al. · Bioengineering & Translational Medicine · 29
PDF
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3
2021 · Elly Marcq, Jonas R. M. Van Audenaerde, et al. · Cancers · 28
PDF
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers
2023 · Laurie Freire Boullosa, Jinthe Van Loenhout, et al. · Antioxidants · 26
PDF
Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model
2015 · Rita Silva-Gomes, Elly Marcq, et al. · PLoS neglected tropical diseases · 24
PDF
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression
2019 · Vasiliki Siozopoulou, Elly Marcq, et al. · Cancer Immunology Immunotherapy · 22
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
2022 · Eline Janssens, Zoë Mol, et al. · Frontiers in Oncology · 18
NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects
2022 · Vasiliki Siozopoulou, Elly Marcq, et al. · Pathology & Oncology Research · 16
PDF
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer
2022 · Yana Debie, Jonas R.M. Van Audenaerde, et al. · Clinical Cancer Research · 14
PDF
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
2022 · Eline Janssens, Eline Schillebeeckx, et al. · Cancers · 12
PDF
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
2022 · Sophie Rovers, Annelies Janssens, et al. · Biomedicines · 12
PDF
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression
2019 · Elly Marcq, Jonas RM Van Audenaerde, et al. · International Journal of Molecular Sciences · 12
PDF
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade
2024 · Nicola Principe, Amber-Lee Phung, et al. · Journal for ImmunoTherapy of Cancer · 11
PDF
Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results
2023 · Kathleen Zwijsen, Eline Schillebeeckx, et al. · Journal of Breath Research · 11
Works count: 85
Citation count: 1,104
H-index: 18
I10-index: 26
Year
Topic
Type